Wednesday, November 18, 2015 10:25:24 AM
Bionik Laboratories Corp. a pioneering medical device and robotics company with a focus in developing technologies and solutions for individuals with neurological disorders gave a presentation at the held October 20-21, 2015 at the Parc 55 in San Francisco, California.
Peter Bloch, CEO of Bionik, presented a corporate overview. As part of his presentation he reviewed the Company's plans for the clinical development and commercial deployment of its primary product ARKE, a proprietary lower-body exoskeleton robotic device that is designed to allow paraplegics as well as other wheelchair users the ability to rehabilitate through walking and other motion. Mr. Bloch also discussed Bionik's near-term strategy to expand and develop a robust product portfolio both internally and by acquiring or licensing synergistic products and technologies.
A live webcast of the presentation is available on Bionik's IR Calendar in the Investor Relations section of the Company's website. A webcast replay is available and will be archived for 30 days.
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM